Ann: New Hires & Attendance at International MND Symposium, page-10

Sounds like we may have a licensing deal for the K9 Treatment.

Bringing in Internal Manufacturing Professionals would indicate its a "Controlled Manufacture and Sale License"

These type of Deals involve the IP Owner e.g Pharmaust controlling the manufacture and delivery to a Re-Seller or Licensed Distributor.

These are great deals as PAA control the Manufacture and PAA get Paid for delivery of each batch , it provides a high degree of control across the manufacturing Process... some licensing deals that involve the Licensee manufacturing can bring unwanted consequences should they not keep to strict GMP exacting quality... Some Asian Countries like to substitute for cheaper ingredients , carriers, preservatives, coatings etc and that is detrimental to the finished product and reputational damage can occur outside of Pharmausts control.

The other benefit is PAA monitor the "Click Rate" when PAA manufacture and Sell 50,000 Tablets we know 50,000 tablets were made,, again some unscrupulous companies would state "we ran 50,000 units , here's your cheque" but they actually ran 75,000 plus units... Bast3rds ..

Moving Forward ,,,, have to put people in place before before we can expect positive action...

No worries on the Money front.... 79m Oppies are 30% closer than they were 18 days ago.... Get your money ready ,,, remember converting your oppies as soon as we pass 16.5c will benefit you directly in case of a T/O Buy out etc... you only get paid for heads not Oppies.... and it keeps control of PAA in the same safe hands.....

After 11.5c the run looks very achievable ,,, News from MT from the Conference and Global Recognition of our Phase I/II results could easily catapult us into the high teens..

BUT YES,, it will take promotion,,,, and we cant expect the same results that other Biotechs receive with out paid content ....NZT